glycemic control
Coverage of glycemic control in the Nexus archive.
- Oral GLP-1 Drug May Simplify Diabetes Treatment
The ACHIEVE-5 trial demonstrated that adding oral orforglipron (Foundayo) to basal insulin improved glycemic control and reduced body weight in diabetes patients. The results were presented at the American Diabetes Association annual meeting.
- Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide
Monotherapy with once-weekly retatrutide, an investigational triple hormone receptor agonist, improved glycemic control and body weight in adults with type 2 diabetes, as shown in the phase III TRANSCEND-T2D-1 trial. Up to 40% of patients achieved normal HbA1c levels.
- Add-On Orforglipron: Good News for Type 2 Diabetes and Inadequate Glycemic Control
Once-daily orforglipron improved outcomes in adults with type 2 diabetes and inadequate glycemic control, according to the ACHIEVE-5 trial. The drug is an add-on treatment for patients already on insulin glargine.